Chronic lymphocytic leukemia with MDM2 amplification as an alternative pathway to TP53 dysfunction

Leuk Lymphoma. 2024 Sep 4:1-4. doi: 10.1080/10428194.2024.2398659. Online ahead of print.

Sally Hunter¹, Georgina Ryland^{1

2}, Jia-Min Pang¹, Slavisa Ninkovic³, Karen Dun^{3

4}, John F Seymour^{5

6}, Piers Blombery^{1

2

5}

¹ Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
² Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
³ Victorian Cancer Cytogenetics Service, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
⁴ Department of Haematology, St. Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
⁵ Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
⁶ Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.

No abstract available